BARDA

@BARDA

Advancing countermeasures against 21st century health threats by bringing together public private partnerships and advancing innovation. Part of HHS/ASPR.

Washington, DC

Joined April 2017

216Following

10KFollowers

Pinned

BARDA Retweeted

HHS ASPR@ASPRgov · Jan 17

This #MLKDay, honor Dr. King's legacy by serving your community. In the latest edition of the ASPR Blog, @MRC_ASPR Deputy Director Spindel urges you to embrace the power of volunteering by joining the Medical Reserve Corps. bit.ly/42i8vNR #DayOfService #Volunteer

3.0K

BARDA@BARDA · Jul 21

We’re seeking proposals under Project BioShield to support procurement and further development of an FDA-approved and commercially available enzymatic debridement product for the treatment of severe burn injuries. Apply to our #RFP by August 27, 2025: ow.ly/bjr150WsU0R

BARDA's tweet image. We’re seeking proposals under Project BioShield to support procurement and further development of an FDA-approved and commercially available enzymatic debridement product for the treatment of severe burn injuries. Apply to our #RFP by August 27, 2025: ow.ly/bjr150WsU0R

378

BARDA@BARDA · Jul 18

We’re seeking proposals under Project BioShield to support the advanced development, @US_FDA licensure, and potential procurement of monovalent vaccines against #Marburg virus and Sudan virus (#SUDV). Apply to our #RFP by August 26, 2025: ow.ly/tSZ950Ws714

BARDA's tweet image. We’re seeking proposals under Project BioShield to support the advanced development, @US_FDA licensure, and potential procurement of monovalent vaccines against #Marburg virus and Sudan virus (#SUDV). Apply to our #RFP by August 26, 2025: ow.ly/tSZ950Ws714

887

BARDA@BARDA · Jul 15

We issued an #RFP under Project BioShield to support advanced development and potential procurement of an antibiotic to treat bloodstream infections or hospital-acquired or ventilator-associated pneumonia caused by #AMR bacteria. Apply by August 26, 2025: ow.ly/pvWj50Wqf2T

BARDA's tweet image. We issued an #RFP under Project BioShield to support advanced development and potential procurement of an antibiotic to treat bloodstream infections or hospital-acquired or ventilator-associated pneumonia caused by #AMR bacteria. Apply by August 26, 2025: ow.ly/pvWj50Wqf2T

1.0K

BARDA@BARDA · Jul 7

Today is the last day to submit a proposal to our Project BioShield #RFP. We’re seeking to support procurement of an approved autograft sparing device to treat burn injuries. Submit by 2:00 PM ET on 7/7. Details and more info: ow.ly/O4su50WlEMM

BARDA's tweet image. Today is the last day to submit a proposal to our Project BioShield #RFP. We’re seeking to support procurement of an approved autograft sparing device to treat burn injuries. Submit by 2:00 PM ET on 7/7. Details and more info: ow.ly/O4su50WlEMM

356

BARDA@BARDA · Jun 13

Help us address long-term burn care challenges and bolster national preparedness. We’re seeking proposals under Project BioShield to support procurement of an approved autograft sparing device to treat burn injuries. Apply to our #RFP by July 7, 2025: ow.ly/ZWxC50W9fU9

BARDA's tweet image. Help us address long-term burn care challenges and bolster national preparedness. We’re seeking proposals under Project BioShield to support procurement of an approved autograft sparing device to treat burn injuries. Apply to our #RFP by July 7, 2025: ow.ly/ZWxC50W9fU9

500

BARDA@BARDA · Jun 13

The 1st patient in the JUST BREATHE phase 2 platform clinical trial investigating novel host-directed therapeutic candidates for acute respiratory distress syndrome has been enrolled! We’re working with @PPD to explore treatments that could save lives: ow.ly/cs9T50W9fpf

BARDA's tweet image. The 1st patient in the JUST BREATHE phase 2 platform clinical trial investigating novel host-directed therapeutic candidates for acute respiratory distress syndrome has been enrolled! We’re working with @PPD to explore treatments that could save lives: ow.ly/cs9T50W9fpf

934

BARDA@BARDA · May 21

Four BARDA-supported #MedicalCountermeasures have recently received @US_FDA approval, licensure, or clearance. Learn more about these products and how BARDA helps enable their accessibility and availability during health security emergencies: medicalcountermeasures.gov/barda/fdaappro…

509

BARDA@BARDA · Jan 19

Tomorrow is the last day to submit your abstract to our Influenza Vaccine Innovation program! We’re seeking to develop novel influenza #vaccines that can provide broader and longer-lasting protection against pandemic #flu Submit by 12 pm ET on 1/20: sam.gov/opp/8f4d63db54…

BARDA's tweet image. Tomorrow is the last day to submit your abstract to our Influenza Vaccine Innovation program! We’re seeking to develop novel influenza #vaccines that can provide broader and longer-lasting protection against pandemic #flu Submit by 12 pm ET on 1/20: sam.gov/opp/8f4d63db54…

2.0K

BARDA@BARDA · Jan 18

We are partnering with @globalsyseng to enhance and modernize CHEMM, our digital resource designed for emergency responders & healthcare providers to access comprehensive information & guidance to aid in preparedness & response for chemical incidents: ow.ly/vkmJ50UIQNl

BARDA's tweet image. We are partnering with @globalsyseng to enhance and modernize CHEMM, our digital resource designed for emergency responders &amp; healthcare providers to access comprehensive information &amp; guidance to aid in preparedness &amp; response for chemical incidents: ow.ly/vkmJ50UIQNl

955

BARDA@BARDA · Jan 17

Have you heard? We’re on the Bluesky bandwagon! Give us a follow at: ow.ly/yyx750UIQgL

839

BARDA@BARDA · Jan 17

Through @RRPV_Consortium, BARDA expands its partnership w/ mRNA vaccine developer @moderna_tx to expand a rapid pandemic #influenza response capability. This effort aims to make safe & effective #vaccines available more quickly during influenza pandemics. ow.ly/Ep2M50UIPRm

BARDA's tweet image. Through @RRPV_Consortium, BARDA expands its partnership w/ mRNA vaccine developer @moderna_tx to expand a rapid pandemic #influenza response capability. This effort aims to make safe &amp; effective #vaccines available more quickly during influenza pandemics. ow.ly/Ep2M50UIPRm

850

BARDA@BARDA · Jan 17

To help sustain a response-ready posture, we support & maintain a portfolio that helps provide long-term access to #MedicalCountermeasures. This approach bolsters national security & enhances preparedness: ow.ly/8FGh50UHRuu

518

BARDA@BARDA · Jan 17

We never stop working to protect the American people. Let’s take a brief look back at our work in 2024 to bolster preparedness for a range of potential health security threats. Learn more: ow.ly/BRwA50UI50y

404

BARDA@BARDA · Jan 16

Through the @RRPV_Consortium, BARDA is partnering with @ShionogiUS to advance a long-acting therapeutic aimed at preventing #COVID19 for people who are immune compromised. Learn more: ow.ly/m7yQ50UHSsY

BARDA's tweet image. Through the @RRPV_Consortium, BARDA is partnering with @ShionogiUS to advance a long-acting therapeutic aimed at preventing #COVID19 for people who are immune compromised. Learn more: ow.ly/m7yQ50UHSsY

325

BARDA@BARDA · Jan 16

We’ve reopened our DRIVe & CBRN ReBooT EZ-BAA area of interest to support the development of repurposed & repositioned direct-acting or host-directed therapeutics to address filovirus (Ebola, Marburg, & Sudan virus) infections. Submission deadline is 4/30: ow.ly/26bk50UGs7Z

BARDA's tweet image. We’ve reopened our DRIVe &amp; CBRN ReBooT EZ-BAA area of interest to support the development of repurposed &amp; repositioned direct-acting or host-directed therapeutics to address filovirus (Ebola, Marburg, &amp; Sudan virus) infections. Submission deadline is 4/30: ow.ly/26bk50UGs7Z

316

BARDA@BARDA · Jan 14

There's still time to submit your abstract to DRIVe & CBRN’s ReDIRECT program! We seek to support the development of repurposed therapeutics to treat injuries caused by chemical threats. Submissions close March 31: ow.ly/aZR550Uk7qF

BARDA's tweet image. There's still time to submit your abstract to DRIVe &amp; CBRN’s ReDIRECT program! We seek to support the development of repurposed therapeutics to treat injuries caused by chemical threats. Submissions close March 31: ow.ly/aZR550Uk7qF

330

BARDA@BARDA · Jan 13

We are thrilled to announce the Concept Stage winners of the #PatchForwardPrize! Learn more about the winners and how the Patch Forward Prize is advancing microneedle patch-based RNA vaccines: ow.ly/yYWF50UFjYB #ProjectNextGen

BARDA's tweet image. We are thrilled to announce the Concept Stage winners of the #PatchForwardPrize! Learn more about the winners and how the Patch Forward Prize is advancing microneedle patch-based RNA vaccines: ow.ly/yYWF50UFjYB #ProjectNextGen

386